NO20012538L - Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet - Google Patents

Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet

Info

Publication number
NO20012538L
NO20012538L NO20012538A NO20012538A NO20012538L NO 20012538 L NO20012538 L NO 20012538L NO 20012538 A NO20012538 A NO 20012538A NO 20012538 A NO20012538 A NO 20012538A NO 20012538 L NO20012538 L NO 20012538L
Authority
NO
Norway
Prior art keywords
nervous system
central nervous
treatment
system disorders
substituted
Prior art date
Application number
NO20012538A
Other languages
English (en)
Other versions
NO20012538D0 (no
Inventor
Rainer Munschauer
Gerd Steiner
Gerhard Gross
Martin Traut
Liliane Unger
Hans-Juergen Teschendorf
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO20012538D0 publication Critical patent/NO20012538D0/no
Publication of NO20012538L publication Critical patent/NO20012538L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)

Abstract

Det er beskrevet anvendelse av N-substituerte 3-azabicykloalkanderivater med formel l hvori B, R1, R2 og n er som definert heri for kontrahering av avhengighetsforstyrrelser og andre forstyrrelser i sentralnervesystemet.
NO20012538A 1998-11-24 2001-05-23 Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet NO20012538L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19854147A DE19854147A1 (de) 1998-11-24 1998-11-24 Verwendung von N-substituierten Azabicycloalkan-Derivaten zur Verwendung bei der Bekämpfung der Cocainsucht
PCT/EP1999/008734 WO2000030639A1 (de) 1998-11-24 1999-11-12 Verwendung von n-substituierten azabicycloalkan-derivaten zur behandlung von erkrankungen des zentralen nervensystems

Publications (2)

Publication Number Publication Date
NO20012538D0 NO20012538D0 (no) 2001-05-23
NO20012538L true NO20012538L (no) 2001-07-04

Family

ID=7888824

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012538A NO20012538L (no) 1998-11-24 2001-05-23 Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet

Country Status (21)

Country Link
EP (1) EP1133293A1 (no)
JP (1) JP2002530333A (no)
KR (1) KR20010080535A (no)
CN (1) CN1328455A (no)
AR (1) AR021502A1 (no)
AU (1) AU1775300A (no)
BG (1) BG105549A (no)
BR (1) BR9915589A (no)
CA (1) CA2352526A1 (no)
CZ (1) CZ20011796A3 (no)
DE (1) DE19854147A1 (no)
HK (1) HK1040933A1 (no)
HR (1) HRP20010472A2 (no)
HU (1) HUP0104416A3 (no)
IL (1) IL143181A0 (no)
NO (1) NO20012538L (no)
PL (1) PL348758A1 (no)
SK (1) SK7112001A3 (no)
TR (1) TR200101476T2 (no)
WO (1) WO2000030639A1 (no)
ZA (1) ZA200103976B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1836183A2 (en) 2004-12-13 2007-09-26 Galileo Pharmaceuticals, Inc. Spiro derivatives as lipoxygenase inhibitors
GB0812310D0 (en) 2008-07-03 2008-08-13 Syngenta Ltd Novel herbicides
WO2014111837A1 (en) * 2013-01-15 2014-07-24 Novartis Ag Use of alpha 7 nicotinic acetylcholine receptor agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004311A1 (en) * 1987-11-12 1989-05-18 American Home Products Corporation Polycyclicamines with psychotropic activity
DE4427648A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-Stubstituierte 3-Azabicyclo[3,2,0,]heptan-Derivate, ihre Herstellung und Verwendung
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
DE4427647A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
WO2000030639A1 (de) 2000-06-02
AU1775300A (en) 2000-06-13
CZ20011796A3 (cs) 2002-05-15
ZA200103976B (en) 2002-05-16
DE19854147A1 (de) 2000-05-25
BR9915589A (pt) 2001-08-07
HK1040933A1 (zh) 2002-06-28
JP2002530333A (ja) 2002-09-17
PL348758A1 (en) 2002-06-03
HUP0104416A2 (hu) 2002-04-29
SK7112001A3 (en) 2001-12-03
BG105549A (en) 2001-12-29
EP1133293A1 (de) 2001-09-19
IL143181A0 (en) 2002-04-21
HUP0104416A3 (en) 2002-11-28
NO20012538D0 (no) 2001-05-23
KR20010080535A (ko) 2001-08-22
TR200101476T2 (tr) 2001-10-22
AR021502A1 (es) 2002-07-24
HRP20010472A2 (en) 2003-04-30
CA2352526A1 (en) 2000-06-02
CN1328455A (zh) 2001-12-26

Similar Documents

Publication Publication Date Title
ATE264846T1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
SE9900100D0 (sv) New compounds
DK0863875T3 (da) Hidtil ukendte 4-(oxyalkoxyphenyl)-3-oxy-piperiner til behandling af hjerte- og nyrelidelser
MXPA02006212A (es) Inhibidores de fosfodiesterasa amp-especifica ciclica.
GEP20022676B (en) 4-Phenyl-Pyridine Derivatives, Method for Their Production and Their Use for Treatment of Disorders Caused by Antagonist of NK-1 Receptors
MXPA03012013A (es) Derivados de 1-oxa-2,8-diaza-spiro[4,5]dec-2-eno sustituidos como medicamento para el tratamiento de dolor.
DE69820632D1 (de) 2-phenyl-substituierte 1-(n-phenylaminoalkyl)-piperazin-derivate
NO996108L (no) 9-oksinerytromycinderivater
NO986111D0 (no) Anvendelse av K-252A derivat for behandling av perifere og sentrale nervefo
NO990433L (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
DK0765320T3 (da) Benzimidazolonderivater med central dopaminerg aktivitet
DK1578740T3 (da) 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet
ATE277072T1 (de) Sapogenin derivate zur behandlung von kognitiven störungen
DK0556332T3 (da) Substituerede tetrahydropyridiner og hydroxypiperidiner som midler til behandling af centralnervesystemet
NO20000957L (no) Forgrenede alkoksy-substituerte 2-aminopyridiner som NOS inhibitorer
CA2474510A1 (en) Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
FI970469A0 (fi) Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus
ES2191341T3 (es) Derivados de la 2-fenoxianilina.
DK1000046T3 (da) Piperazinderivater, der er aktive på den nedre urinvejskanal
NO20012538L (no) Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet
NZ511997A (en) Isonipecotamides for the treatment of integrin-mediated disorders
AP2002002595A0 (en) Heterocyclic amide derivatives.
NO20010626L (no) N-substituerte azabicykloheptanderivater, deres fremstilling og anvendelse
MY136138A (en) Hexacyclic compounds
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application